ChemImpex 4-Demethylepipodophyllotoxin; >= 99% (HPLC); 6559-91-7; MFCD00189421, 100G

4-Demethylepipodophyllotoxin is a naturally occurring lignan derivative known for its significant pharmacological properties. This compound is primarily recognized for its role in cancer research, particularly as a potential chemotherapeutic agent. Its unique structure allows it to inhibit topoisomerase II, an enzyme critical for DNA replication, making it a valuable candidate in the development of anti-cancer therapies. Researchers have explored its efficacy in treating various malignancies, including leukemia and solid tumors, showcasing its potential to enhance the effectiveness of existing treatments.

In addition to its applications in oncology, 4-Demethylepipodophyllotoxin has been investigated for its anti-inflammatory and antiviral properties, broadening its relevance in pharmaceutical research. Its ability to modulate cellular pathways positions it as a promising lead compound for the development of new therapeutic agents. With ongoing studies, this compound continues to hold potential for innovative applications in both research and clinical settings, making it a valuable addition to any laboratory focused on drug discovery and development.

Specifications

Safety & Regulations